Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Bullous pyoderma gangrenosum can develop on cesarean scars and may require steroids for treatment.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

PRP is an effective and safe treatment for alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Tph cells are linked to the severity of systemic lupus erythematosus.

New genetic discoveries may lead to better treatments for alopecia areata.

The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Treating H. pylori infection might help cure alopecia areata.

Phospholipase A2 enzymes play key roles in skin health and disease.

Targeting Vδ1+T-cells may help treat alopecia areata.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Grateloupia elliptica extract may help prevent hair loss and promote hair growth.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.